New nasal spray aims to stop colds and flu before they start
NCT ID NCT07222670
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational nasal spray called INNA-051 to see if it can safely prevent or reduce the severity of viral respiratory infections like colds and flu. It involves 1100 healthy adults aged 18 to 45 who are at higher risk due to their living or work conditions. Participants receive either the spray or a placebo once weekly for 4 or 12 weeks during respiratory virus season.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRAL RESPIRATORY ILLNESSES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Accellacare - Wilmington
RECRUITINGWilmington, North Carolina, 20841, United States
-
Accellacare of Piedmont HealthCare
RECRUITINGStatesville, North Carolina, 28625, United States
-
Accellacare of Raleigh
RECRUITINGRaleigh, North Carolina, 27609, United States
-
Center for Vaccine Development and Global Health (CVD)
RECRUITINGBaltimore, Maryland, 21201, United States
-
Naval Medical Research Command (NMRC)
RECRUITINGBethesda, Maryland, 20889, United States